Picture of Allergy Therapeutics logo

AGY Allergy Therapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapNeutral

Brief: Allergy Therapeutics Says Ordinary Shares To Be Suspended From Trading On AIM

Dec 15 (Reuters) - Allergy Therapeutics PLC  AGY.L :
    * ANNUAL REPORT AND ACCOUNTS DELAYED
    * COMPANY'S ORDINARY SHARES WILL BE SUSPENDED FROM TRADING
ON AIM
WITH EFFECT FROM 7.30 A.M. ON 2 JANUARY 2024.

Source text for Eikon:  ID:nRSO0237Xa 
Further company coverage:  AGY.L 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Allergy Therapeutics

See all news